tiprankstipranks
Shield Therapeutics PLC (GB:STX)
LSE:STX
UK Market
STX
Shield Therapeutics
RESEARCH TOOLSreports

Shield Therapeutics (STX) Stock News & Sentiment

42 Followers
Shield Therapeutics Hits Record ACCRUFeR Sales and Turns Cash-Flow Positive in 2025
Premium
Company Announcements
Shield Therapeutics Hits Record ACCRUFeR Sales and Turns Cash-Flow Positive in 2025
2d ago
Shield Therapeutics Gains Pediatric Boost as Ferric Maltol Data Published in Leading Journal
Premium
Company Announcements
Shield Therapeutics Gains Pediatric Boost as Ferric Maltol Data Published in Leading Journal
10d ago
Shield Therapeutics updates share capital and underscores global iron deficiency franchise
Premium
Company Announcements
Shield Therapeutics updates share capital and underscores global iron deficiency franchise
11d ago
Shield Therapeutics gains EMA backing to extend FeRACCRU use to adolescents
Premium
Company Announcements
Shield Therapeutics gains EMA backing to extend FeRACCRU use to adolescents
11d ago
Shield Therapeutics Advances ACCRUFeR Into China With NMPA Filing Acceptance
Premium
Company Announcements
Shield Therapeutics Advances ACCRUFeR Into China With NMPA Filing Acceptance
1M ago
Shield Therapeutics Updates Voting Rights as Iron Drug Expansion Continues
Premium
Company Announcements
Shield Therapeutics Updates Voting Rights as Iron Drug Expansion Continues
1M ago
Shield Therapeutics Wins Extra U.S. FDA Exclusivity for ACCRUFeR Pediatric Use
Premium
Company Announcements
Shield Therapeutics Wins Extra U.S. FDA Exclusivity for ACCRUFeR Pediatric Use
2M ago
More GB:STX News >

STX News on the Web

Shield Therapeutics Hits Record ACCRUFeR Sales and Turns Cash-Flow Positive in 2025
TipRanks News
Neutral
Shield Therapeutics Gains Pediatric Boost as Ferric Maltol Data Published in Leading Journal
TipRanks News
Neutral
Shield Therapeutics updates share capital and underscores global iron deficiency franchise
TipRanks News
Neutral
Shield Therapeutics gains EMA backing to extend FeRACCRU use to adolescents
TipRanks News
Neutral
ProKidney appoints Greg Madison as chief commercial officer
TipRanks News
Neutral
Shield Therapeutics Advances ACCRUFeR Into China With NMPA Filing Acceptance
TipRanks News
Neutral
Shield Therapeutics Updates Voting Rights as Iron Drug Expansion Continues
TipRanks News
Neutral
Shield shares jump after FDA extends Accrufer exclusivity
Proactive Investors
Bullish

News Score - Last 7 Days

Neutral
GB:STX
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:STX’s Media Buzz Sentiment?
1 articles about GB:STX were published this week. In an average week, 1.25 articles are published.
    What is GB:STX’s weekly average amount of articles?
    In an average week, 1.25 articles about GB:STX are published.
      What is GB:STX’s News Sentiment?
      50% of articles about GB:STX were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week